Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2019-06-21
HEBHemispherx Biopharma IncAppelrouth StewartDirP - Purchase$4.03+9,67726,708+57%+$38,998
2019-06-20
CHRSCoherus Biosciences, Inc.Healy JamesDirS - Sale$21.37-317,1302,293,313-12%-$6,777,068
D
2019-06-20
RUBYRubius Therapeutics, Inc.Carpenter Christopher L.Chief Medical OfficerS - Sale+OE$13.93-24334,843-1%-$3,386
2019-06-21
HEBHemispherx Biopharma IncSpringate Wayne SSVP of OperationsP - Purchase$4.03+5,2118,672+151%+$21,000
2019-06-21
HEBHemispherx Biopharma IncMitchell William MDirP - Purchase$4.03+9,67720,838+87%+$38,998
2019-06-20
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$9.00+30084,5270%+$2,700
2019-06-20
MNTAMomenta Pharmaceuticals IncManning Anthony M.Chief Scientific OfficerS - Sale$13.00-39,4336,980-85%-$512,629
D
2019-06-19
RGNXRegenxbio Inc.Mills Kenneth T.Pres, CEOS - Sale+OE$52.54-15,000246,000-6%-$788,088
2019-06-21
HEBHemispherx Biopharma IncEquels Thomas K.Exec. Vice COB, CEO, PresP - Purchase$4.03+29,4041,393,611+2%+$118,498
D
2019-06-18
NBIXNeurocrine Biosciences IncBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$87.82-2,100141,976-1%-$184,417
2019-06-18
GILDGilead Sciences IncPletcher Brett AEVP, GC, Corp SecS - Sale$68.75-5,81627,198-18%-$399,850
D
2019-06-18
BLUEBluebird Bio, Inc.Walsh Jeffrey T.Chief Strategy OfficerS - Sale+OE$126.12-10040,9210%-$12,612
D
2019-06-18
RGNXRegenxbio Inc.Christmas Patrick J.SVP, GCS - Sale+OE$52.99-5,0003,006-62%-$264,965
DM
2019-06-18
CHRSCoherus Biosciences, Inc.Viret Jean-FredericCFOS - Sale+OE$19.85-6,82611,513-37%-$135,514
DM
2019-06-17
RUBYRubius Therapeutics, Inc.Carpenter Christopher L.Chief Medical OfficerS - Sale+OE$14.02-47,75734,843-58%-$669,694
M
2019-06-17
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$10.59+80084,227+1%+$8,468
AD
2019-05-23
RGENRepligen CorpCooper Glenn L MdDirS - Sale+OE$66.94-5,00059,709-8%-$334,715
D
2019-06-17
RGENRepligen CorpDawes Karen ADirS - Sale+OE$77.35-1,295117,034-1%-$100,168
2019-06-17
SGENSeattle Genetics Inc /waDansey Roger DChief Medical OfficerS - Sale$68.60-5,41677,593-7%-$371,538
D
2019-06-17
CRSPCrispr Therapeutics AGKulkarni SamarthCEOS - Sale+OE$46.00-20,000165,801-11%-$920,000
2019-06-14
XLRNAcceleron Pharma IncZakrzewski Joseph SDirP - Purchase$38.05+5,00012,750+65%+$190,250
D
2019-06-13
NBIXNeurocrine Biosciences IncBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$82.62-17,268141,976-11%-$1,426,628
D
2019-06-12
TECHBio-Techne CorpEansor Norman DavidSVP - Novus BiologicalsS - Sale+OE$215.00-3,1170-100%-$670,155
2019-05-10
CRTXCortexyme, Inc.Epiq Capital Group, LLCIA/Managing Member 10% ownerP - Purchase$26.98+8,6008,476,0580%+$232,056
M
2019-06-11
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$9.95+40083,4280%+$3,979
2019-06-11
PTEPolarityte, Inc.Swanson Edward WinslowChief Trans. Med. OfficerP - Purchase$5.66+2,00037,661+6%+$11,315
2019-06-10
DNLIDenali Therapeutics Inc.Schuth Alexander O.COO, SecretaryS - Sale$18.77-7,500648,327-1%-$140,775
D
2019-06-10
DNLIDenali Therapeutics Inc.Ho CaroleChief Medical OfficerS - Sale+OE$18.78-17,500162,798-10%-$328,653
D
2019-06-10
SGENSeattle Genetics Inc /waSiegall Clay BPres, CEOS - Sale+OE$69.05-20,148746,294-3%-$1,391,175
2019-06-10
PTEPolarityte, Inc.Gorlin SteveDirS - Sale$5.94-53,7001,300-98%-$318,978
D
2019-06-10
BLUEBluebird Bio, Inc.Walsh Jeffrey T.Chief Strategy OfficerS - Sale+OE$125.44-1,40040,921-3%-$175,619
2019-06-10
CRSPCrispr Therapeutics AGNovak RodgerPresS - Sale$45.00-50,000898,007-5%-$2,250,000
D
2019-06-10
VCELVericel CorpMichel Gerard JCFO, VP, Corp. DevelopmentS - Sale+OE$15.62-17,500122,672-12%-$273,373
D
2019-06-10
EVFMEvofem Biosciences, Inc.Pdl Biopharma, Inc.10%P - Purchase$4.50+6,666,66713,333,334+100%+$30,000,002
D
2019-06-06
BLUEBluebird Bio, Inc.Davidson DavidChief Medical OfficerS - Sale+OE$122.64-5,06031,616-14%-$620,539
2019-06-07
MCTCMcTc Holdings, Inc.Lauderdale Holdings, LLCPres, 10%S - Sale$0.00-130,000,0000-100%-$325,000
M
2019-06-06
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$11.14+23583,0280%+$2,619
2019-06-05
NSTGNanostring Technologies IncGhesquiere David W.SVP, Corporate, Business DevS - Sale$29.41-6,95444,868-13%-$204,493
2019-06-06
ADMAAdma Biologics, Inc.Biotest Divestiture Trust10%S - Sale$3.75-5,813,9544,295,580-58%-$21,802,328
2019-06-05
BLUEBluebird Bio, Inc.Wentworth Kory JamesPrincipal Accounting OfficerS - Sale$127.60-616,846-1%-$7,784
D
2019-06-05
BLUEBluebird Bio, Inc.Gregory Philip DChief Scientific OfficerS - Sale+OE$128.60-1,80031,092-5%-$231,488
2019-06-05
APTOAptose Biosciences Inc.Chow Gregory K.SVP, CFOP - Purchase$1.84+7,500134,514+6%+$13,815
D
2019-06-04
TECHBio-Techne CorpHiggins John LDirS - Sale+OE$203.67-5,0003,526-59%-$1,018,346
2019-06-05
PTEPolarityte, Inc.Swanson Edward WinslowChief Trans Med OfficerP - Purchase$5.68+2,00035,661+6%+$11,367
2019-06-05
PTEPolarityte, Inc.Seaburg David BPres of Corp DevelopmentP - Purchase$5.93+35,000100,000+54%+$207,550
2019-06-05
PTEPolarityte, Inc.Mann Paul ElliotCFOP - Purchase$5.33+35,000156,247+29%+$186,519
2019-06-05
PTEPolarityte, Inc.Cohen Peter ADirP - Purchase$5.63+15,00072,500+26%+$84,471
M
2019-06-04
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$1.02+2,000745,1420%+$2,039
D
2019-06-05
AMGNAmgen IncSugar Ronald DDirS - Sale+OE$175.68-2,00014,219-12%-$351,360
D
2019-06-03
NBIXNeurocrine Biosciences IncBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$85.51-3,435141,976-2%-$293,719
D
2019-06-03
ALLOAllogene Therapeutics, Inc.Moore AlisonChief Technical OfficerS - Sale+OE$26.76-48,82837,557-57%-$1,306,774
2019-06-03
DNLIDenali Therapeutics Inc.Watts Ryan J.Pres, CEOS - Sale$19.07-18,3332,573,476-1%-$349,610
2019-06-03
INMBInmune Bio, Inc.Powers Linda F10%P - Purchase$6.00+10,0001,130,000+1%+$60,000
D
2019-05-31
SGENSeattle Genetics Inc /waHimes Vaughn BChief Technical OfficerS - Sale+OE$65.94-8,000177,329-4%-$527,485
2019-06-03
INMBInmune Bio, Inc.Juda ScottDirP - Purchase$6.00+10,00022,500+80%+$60,000
2019-06-03
INMBInmune Bio, Inc.Moss David JCFO, Treasurer, Secretary, 10%P - Purchase$6.00+10,0001,220,417+1%+$60,000
2019-06-03
INMBInmune Bio, Inc.Tesi Raymond JosephPres, CEO, 10%P - Purchase$6.00+10,0001,536,933+1%+$60,000
2019-05-30
HSKAHeska CorpHumphrey ScottDirP - Purchase$73.79+1,0003,062+48%+$73,790
D
2019-05-31
NBIXNeurocrine Biosciences IncBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$85.02-19,297141,976-12%-$1,640,581
2019-05-30
CHRSCoherus Biosciences, Inc.Lanfear Dennis MPres, CEOS - Sale$19.49-32,3981,496,166-2%-$631,282
M
2019-05-29
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$23.09-5,850622,930-1%-$135,089
D
2019-05-28
RGNXRegenxbio Inc.Simpson CurranSVP, Product Development, CTOS - Sale+OE$50.00-18,00039,500-31%-$900,000
2019-05-28
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$1.28+200743,1420%+$256
D
2019-05-24
NBIXNeurocrine Biosciences IncBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$80.03-17,486141,976-11%-$1,399,434
D
2019-05-24
TECHBio-Techne CorpFurlow Brenda S.SVP - GCS - Sale+OE$200.00-5,4002,189-71%-$1,080,000
2019-05-23
RGENRepligen CorpCooper Glenn L MdDirS - Sale$66.94-5,00035,709-12%-$334,715
2019-05-22
CHRSCoherus Biosciences, Inc.Healy JamesDirS - Sale$20.69-257,8702,610,443-9%-$5,335,330
2019-05-22
BCRXBiocryst Pharmaceuticals IncAselage SteveDirP - Purchase$3.57+3,0005,000+150%+$10,710
D
2019-05-22
NBIXNeurocrine Biosciences IncBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$80.03-1,300141,976-1%-$104,037
D
2019-05-21
ADMAAdma Biologics, Inc.Perceptive Advisors LLC10%P - Purchase$4.00+4,000,00011,521,102+53%+$16,000,000
D
2019-05-20
RGNXRegenxbio Inc.Mills Kenneth T.Pres, CEOS - Sale+OE$42.99-15,000246,000-6%-$644,866
2019-05-21
CVMCel Sci CorpYoung Peter RDirP - Purchase$5.00+2,00021,091+10%+$10,000
2019-05-17
ADMAAdma Biologics, Inc.Grossman Jerrold BDirP - Purchase$4.00+12,000179,857+7%+$48,000
2019-05-17
ADMAAdma Biologics, Inc.Guiheen Lawrence P.DirP - Purchase$4.00+25,00051,000+96%+$100,000
2019-05-17
ADMAAdma Biologics, Inc.Mond JamesEVP, CSO, CMOP - Purchase$4.00+4,50017,889+34%+$18,000
2019-05-17
ADMAAdma Biologics, Inc.Lenz BrianEVP, CFOP - Purchase$4.00+5,00025,000+25%+$20,000
2019-05-17
ADMAAdma Biologics, Inc.Grossman Adam SPres, CEOP - Purchase$4.00+30,0001,439,785+2%+$120,000
A
2019-05-02
INMBInmune Bio, Inc.Tesi Raymond JosephPres, CEO, 10%P - Purchase$10.75+11,1001,526,933+1%+$119,325
A
2019-05-06
INMBInmune Bio, Inc.Moss David JCFO, Treasurer, Secretary, 10%P - Purchase$10.71+5,0001,210,4170%+$53,550
M
2019-05-16
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$1.15+2,100742,9420%+$2,422
D
2019-05-16
NBIXNeurocrine Biosciences IncBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$80.13-66,667141,976-32%-$5,341,893
D
2019-05-17
LIFEAtyr Pharma IncKrueger NancyGCS - Sale+OE$0.45-4,65125,348-16%-$2,093
DM
2019-05-16
BCRXBiocryst Pharmaceuticals IncStaab Thomas R IISVP, CFOS - Sale+OE$7.65-9,750125,176-7%-$74,595
D
2019-05-16
FATEFate Therapeutics IncWolchko J ScottPres, CEOS - Sale+OE$19.37-14,335374,881-4%-$277,684
D
2019-05-15
SGMOSangamo Therapeutics, IncYi KathyEVP, CFOS - Sale+OE$10.00-5,00025,512-16%-$50,000
DM
2019-05-14
BCRXBiocryst Pharmaceuticals IncStaab Thomas R IISVP, CFOS - Sale+OE$7.81-11,750130,176-8%-$91,710
2019-05-14
HARPHarpoon Therapeutics, Inc.McMahon Gerald PhdPres, CEOP - Purchase$10.16+1,0003,000+50%+$10,157
2019-05-13
NBIXNeurocrine Biosciences IncGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale$75.44-1,657118,408-1%-$125,007
D
2019-05-13
NBIXNeurocrine Biosciences IncBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$75.51-34,547141,976-20%-$2,608,813
D
2019-05-14
MNTAMomenta Pharmaceuticals IncWheeler Craig APres, CEOS - Sale+OE$13.72-2,778507,996-1%-$38,114
D
2019-05-13
BOLDAudentes Therapeutics, Inc.Prasad SuyashSVP, Chief Med OfficerS - Sale+OE$36.98-10,00018,236-35%-$369,798
M
2019-05-13
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$24.61-7,800628,780-1%-$191,973
2019-05-13
NSTGNanostring Technologies IncGray R BradleyPres, CEOS - Sale$26.59-50,00026,530-65%-$1,329,421
D
2019-05-13
AXLAAxcella Health Inc.Flagship Ventures Fund IV General Partner LLC10%P - Purchase$20.00+500,0003,700,463+16%+$10,000,000
2019-05-14
ALLOAllogene Therapeutics, Inc.Tpg Group Holdings (Sbs) Advisors, Inc.10%S - Sale$29.38-1,918,75521,216,306-8%-$56,373,022
2019-05-10
MNTAMomenta Pharmaceuticals IncManning Anthony M.Chief Scientific OfficerS - Sale$14.00-11446,4130%-$1,596
2019-05-10
MNTAMomenta Pharmaceuticals IncWheeler Craig APres, CEOS - Sale$14.13-1,772504,6020%-$25,038
2019-05-10
MNTAMomenta Pharmaceuticals IncBeltramello Jo AnnChief HR, Inf. OfficerS - Sale$14.00-35469,085-1%-$4,956
D
2019-05-10
MNTAMomenta Pharmaceuticals IncKwon YoungSVP, Chief Business OfficerS - Sale+OE$14.00-35499,5180%-$4,956
2019-05-10
MNTAMomenta Pharmaceuticals IncFier IanChief Mfg, Program OfficerS - Sale$14.00-3544,871-7%-$4,956
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top